GB1585316A - Erythromycin a intermediates - Google Patents

Erythromycin a intermediates Download PDF

Info

Publication number
GB1585316A
GB1585316A GB34309/79A GB3430979A GB1585316A GB 1585316 A GB1585316 A GB 1585316A GB 34309/79 A GB34309/79 A GB 34309/79A GB 3430979 A GB3430979 A GB 3430979A GB 1585316 A GB1585316 A GB 1585316A
Authority
GB
United Kingdom
Prior art keywords
formula
compound
hydrogen
alkanoyl
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB34309/79A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/856,479 external-priority patent/US4150220A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of GB1585316A publication Critical patent/GB1585316A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB34309/79A 1977-02-04 1978-02-02 Erythromycin a intermediates Expired GB1585316A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76548077A 1977-02-04 1977-02-04
US05/856,479 US4150220A (en) 1977-02-04 1977-12-01 Semi-synthetic 4"-erythromycin A derivatives

Publications (1)

Publication Number Publication Date
GB1585316A true GB1585316A (en) 1981-02-25

Family

ID=27117613

Family Applications (2)

Application Number Title Priority Date Filing Date
GB34309/79A Expired GB1585316A (en) 1977-02-04 1978-02-02 Erythromycin a intermediates
GB4165/78A Expired GB1585315A (en) 1977-02-04 1978-02-02 Erythromycin a derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB4165/78A Expired GB1585315A (en) 1977-02-04 1978-02-02 Erythromycin a derivatives

Country Status (30)

Country Link
JP (1) JPS5827798B2 (fr)
AR (1) AR222147A1 (fr)
AU (1) AU501298B1 (fr)
BG (2) BG32718A3 (fr)
CA (1) CA1106367A (fr)
CH (1) CH628906A5 (fr)
CS (1) CS221801B2 (fr)
DD (1) DD140048A5 (fr)
DE (1) DE2804507C2 (fr)
DK (1) DK148036C (fr)
ES (2) ES466057A1 (fr)
FI (1) FI780354A (fr)
FR (2) FR2379550A1 (fr)
GB (2) GB1585316A (fr)
GR (1) GR68691B (fr)
HU (1) HU182559B (fr)
IE (1) IE46661B1 (fr)
IL (2) IL53968A0 (fr)
IT (1) IT1094209B (fr)
LU (1) LU79004A1 (fr)
NL (1) NL176174C (fr)
NO (2) NO146472C (fr)
NZ (1) NZ186385A (fr)
PH (2) PH14421A (fr)
PL (1) PL116228B1 (fr)
PT (1) PT67568B (fr)
RO (4) RO77345A (fr)
SE (2) SE445223B (fr)
SU (1) SU927122A3 (fr)
YU (3) YU40913B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives

Also Published As

Publication number Publication date
FR2385735B1 (fr) 1980-10-24
GR68691B (fr) 1982-02-01
FR2385735A1 (fr) 1978-10-27
NO146472B (no) 1982-06-28
RO81622A (fr) 1983-04-29
HU182559B (en) 1984-02-28
IT7820005A0 (it) 1978-02-03
ES472429A1 (es) 1979-04-01
YU40799B (en) 1986-06-30
DK51878A (da) 1978-08-05
PH14421A (en) 1981-07-10
NL176174B (nl) 1984-10-01
NO150484C (no) 1984-10-24
IL53968A0 (en) 1978-04-30
SE8300870L (sv) 1983-02-16
PT67568B (en) 1979-06-18
RO79687A7 (fr) 1982-08-17
SE445223B (sv) 1986-06-09
GB1585315A (en) 1981-02-25
IE780239L (en) 1978-08-04
RO81622B (ro) 1983-04-30
NL176174C (nl) 1985-03-01
PT67568A (en) 1978-02-01
AU501298B1 (en) 1979-06-14
BG33159A3 (en) 1982-12-15
YU227983A (en) 1984-04-30
IL61997A0 (en) 1981-02-27
SE457086B (sv) 1988-11-28
CS221801B2 (en) 1983-04-29
FR2379550A1 (fr) 1978-09-01
LU79004A1 (fr) 1979-09-06
YU40798B (en) 1986-06-30
PL204428A1 (pl) 1979-06-04
RO79686A7 (fr) 1982-08-17
YU40913B (en) 1986-08-31
ES466057A1 (es) 1978-10-01
FR2379550B1 (fr) 1980-07-04
IE46661B1 (en) 1983-08-24
CA1106367A (fr) 1981-08-04
BG32718A3 (en) 1982-09-15
SE8300870D0 (sv) 1983-02-16
CH628906A5 (en) 1982-03-31
NO150484B (no) 1984-07-16
NO780389L (no) 1978-08-07
YU7378A (en) 1983-04-30
FI780354A (fi) 1978-08-05
DE2804507C2 (de) 1982-11-04
YU26583A (en) 1984-02-29
DD140048A5 (de) 1980-02-06
DE2804507A1 (de) 1978-08-10
NO146472C (no) 1982-10-06
RO77345A (fr) 1981-08-17
DK148036C (da) 1985-07-15
NL7801262A (nl) 1978-08-08
DK148036B (da) 1985-02-11
SU927122A3 (ru) 1982-05-07
PL116228B1 (en) 1981-05-30
SE7800270L (sv) 1978-08-05
PH16675A (en) 1983-12-13
NO811913L (no) 1978-08-07
AR222147A1 (es) 1981-04-30
NZ186385A (en) 1980-10-08
IT1094209B (it) 1985-07-26
JPS5827798B2 (ja) 1983-06-11
JPS53101337A (en) 1978-09-04

Similar Documents

Publication Publication Date Title
EP0180415B1 (fr) Dérivé de la 6-0-méthylérythromycine
RU2230748C2 (ru) Способ получения кларитромицина в виде кристаллов формы ii
EP0109253B1 (fr) Dérivé épimère de l'azahomoérythromycine A et intermédiaires
EP0638585B1 (fr) Derive de 5-o-desosaminylerythronolide a
EP0827965B1 (fr) Synthèse de 9-déoxo-9a-aza 11,12-déoxy-9a-méthyl-9a-homoérythromycin A 11,12-hydrogenorthoborate dihydrate
EP0087905B1 (fr) 4"-Epi erythromycine A et ses dérivés utilisables comme agents antibactériens
US4150220A (en) Semi-synthetic 4"-erythromycin A derivatives
US4382086A (en) 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
GB1585316A (en) Erythromycin a intermediates
CA2009370A1 (fr) Macrolides
HU211975A9 (en) Derivatives of tylosin and 10,11,12,13-tetrahydrotylosin and their use in pharmaceuticals
DE602004003054T2 (de) Neue 3-decladinosyl-9a-n-carbamoyl- und 9a-n-thiocarbamoylderivate von 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a
CA1106366A (fr) Derives semi-synthetiques de 4"-aminooleandomycine
AU610160B2 (en) New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
RU2234510C2 (ru) Производные класса олеандомицина и способ их получения
US4124755A (en) 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
IE46662B1 (en) Erythromycin a intermediates
CA1128506A (fr) Derives de 4"-erythromycine a semi-synthetiques
EP0087915B1 (fr) Oléandomycines et erythromycines semi-synthétiques
KR820001220B1 (ko) 반합성 4"-에리트로마이신 a 유도체의 제조방법
US4098994A (en) Sulfamide derivatives of 4 -deoxy-oleandomycin
EP0490311B1 (fr) Dérivés de 10,11,12,13-tetra-hydrodesmycosin, procédé pour leur préparation, et leur utilisation dans la production des pharmaceutiques
CA1250284A (fr) Derive d'azahomoerythromycine epimere antibacterien et methode de production dudit derive
KR820001219B1 (ko) 반합성 4"-에리트로마이신 a 유도체의 제조방법

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940202